275 related articles for article (PubMed ID: 17220236)
1. Zonal gene expression in mouse liver resembles expression patterns of Ha-ras and beta-catenin mutated hepatomas.
Braeuning A; Ittrich C; Köhle C; Buchmann A; Schwarz M
Drug Metab Dispos; 2007 Apr; 35(4):503-7. PubMed ID: 17220236
[TBL] [Abstract][Full Text] [Related]
2. Serum components and activated Ha-ras antagonize expression of perivenous marker genes stimulated by beta-catenin signaling in mouse hepatocytes.
Braeuning A; Menzel M; Kleinschnitz EM; Harada N; Tamai Y; Köhle C; Buchmann A; Schwarz M
FEBS J; 2007 Sep; 274(18):4766-77. PubMed ID: 17697114
[TBL] [Abstract][Full Text] [Related]
3. Zonation of heme synthesis enzymes in mouse liver and their regulation by β-catenin and Ha-ras.
Braeuning A; Schwarz M
Biol Chem; 2010 Nov; 391(11):1305-13. PubMed ID: 20707599
[TBL] [Abstract][Full Text] [Related]
4. Wnt/beta-catenin signaling activates and determines hepatic zonal expression of glutathione S-transferases in mouse liver.
Giera S; Braeuning A; Köhle C; Bursch W; Metzger U; Buchmann A; Schwarz M
Toxicol Sci; 2010 May; 115(1):22-33. PubMed ID: 20118494
[TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype relationships in hepatocellular tumors from mice and man.
Stahl S; Ittrich C; Marx-Stoelting P; Köhle C; Altug-Teber O; Riess O; Bonin M; Jobst J; Kaiser S; Buchmann A; Schwarz M
Hepatology; 2005 Aug; 42(2):353-61. PubMed ID: 15965925
[TBL] [Abstract][Full Text] [Related]
6. Zonal gene expression in murine liver: lessons from tumors.
Hailfinger S; Jaworski M; Braeuning A; Buchmann A; Schwarz M
Hepatology; 2006 Mar; 43(3):407-14. PubMed ID: 16496347
[TBL] [Abstract][Full Text] [Related]
7. Inducibility of drug-metabolizing enzymes by xenobiotics in mice with liver-specific knockout of Ctnnb1.
Braeuning A; Sanna R; Huelsken J; Schwarz M
Drug Metab Dispos; 2009 May; 37(5):1138-45. PubMed ID: 19237511
[TBL] [Abstract][Full Text] [Related]
8. Differential gene expression in periportal and perivenous mouse hepatocytes.
Braeuning A; Ittrich C; Köhle C; Hailfinger S; Bonin M; Buchmann A; Schwarz M
FEBS J; 2006 Nov; 273(22):5051-61. PubMed ID: 17054714
[TBL] [Abstract][Full Text] [Related]
9. A beta-catenin-dependent pathway regulates expression of cytochrome P450 isoforms in mouse liver tumors.
Loeppen S; Koehle C; Buchmann A; Schwarz M
Carcinogenesis; 2005 Jan; 26(1):239-48. PubMed ID: 15471898
[TBL] [Abstract][Full Text] [Related]
10. Target genes of the WNT/beta-catenin pathway in Wilms tumors.
Zirn B; Samans B; Wittmann S; Pietsch T; Leuschner I; Graf N; Gessler M
Genes Chromosomes Cancer; 2006 Jun; 45(6):565-74. PubMed ID: 16575872
[TBL] [Abstract][Full Text] [Related]
11. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules.
Rebouissou S; Couchy G; Libbrecht L; Balabaud C; Imbeaud S; Auffray C; Roskams T; Bioulac-Sage P; Zucman-Rossi J
J Hepatol; 2008 Jul; 49(1):61-71. PubMed ID: 18466996
[TBL] [Abstract][Full Text] [Related]
12. p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesions.
Kalkuhl A; Troppmair J; Buchmann A; Stinchcombe S; Buenemann CL; Rapp UR; Kaestner K; Schwarz M
Hepatology; 1998 Apr; 27(4):1081-8. PubMed ID: 9537449
[TBL] [Abstract][Full Text] [Related]
13. Comparative transcriptome and proteome analysis of Ha-ras and B-raf mutated mouse liver tumors.
Rignall B; Ittrich C; Krause E; Appel KE; Buchmann A; Schwarz M
J Proteome Res; 2009 Aug; 8(8):3987-94. PubMed ID: 19476384
[TBL] [Abstract][Full Text] [Related]
14. Ha-ras and β-catenin oncoproteins orchestrate metabolic programs in mouse liver tumors.
Unterberger EB; Eichner J; Wrzodek C; Lempiäinen H; Luisier R; Terranova R; Metzger U; Plummer S; Knorpp T; Braeuning A; Moggs J; Templin MF; Honndorf V; Piotto M; Zell A; Schwarz M
Int J Cancer; 2014 Oct; 135(7):1574-85. PubMed ID: 24535843
[TBL] [Abstract][Full Text] [Related]
15. [Role of Wnt/beta-catenin signaling transduction pathway in rat hepatocarcinogenesis].
Wang QM; Li X; Jia LQ; Yang KM; Zhou HY; Yang HJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):454-7. PubMed ID: 16806007
[TBL] [Abstract][Full Text] [Related]
16. Rex3 (reduced in expression 3) as a new tumor marker in mouse hepatocarcinogenesis.
Braeuning A; Jaworski M; Schwarz M; Köhle C
Toxicology; 2006 Oct; 227(1-2):127-35. PubMed ID: 16959394
[TBL] [Abstract][Full Text] [Related]
17. Hepatomas with activating Ctnnb1 mutations in 'Ctnnb1-deficient' livers: a tricky aspect of a conditional knockout mouse model.
Sekine S; Ogawa R; Kanai Y
Carcinogenesis; 2011 Apr; 32(4):622-8. PubMed ID: 21216847
[TBL] [Abstract][Full Text] [Related]
18. Proteome analysis of chemically induced mouse liver tumors with different genotype.
Strathmann J; Paal K; Ittrich C; Krause E; Appel KE; Glauert HP; Buchmann A; Schwarz M
Proteomics; 2007 Sep; 7(18):3318-31. PubMed ID: 17722141
[TBL] [Abstract][Full Text] [Related]
19. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors.
Aydinlik H; Nguyen TD; Moennikes O; Buchmann A; Schwarz M
Oncogene; 2001 Nov; 20(53):7812-6. PubMed ID: 11753661
[TBL] [Abstract][Full Text] [Related]
20. Human homolog of NOTUM, overexpressed in hepatocellular carcinoma, is regulated transcriptionally by beta-catenin/TCF.
Torisu Y; Watanabe A; Nonaka A; Midorikawa Y; Makuuchi M; Shimamura T; Sugimura H; Niida A; Akiyama T; Iwanari H; Kodama T; Zeniya M; Aburatani H
Cancer Sci; 2008 Jun; 99(6):1139-46. PubMed ID: 18429952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
